Drugs / Nepro
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT00179205 Comparator | May 2005 → Nov 2006 | end stage renal failure | Vanderbilt University | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT00179140 Comparator | Nov 2002 → Feb 2006 | end stage renal failure | Vanderbilt University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nepro | “oral administration of protein supplement (Nepro) during hemodialysis; every other day, 3 days per week for 6 months; Nepro is a lactose-free formula that contains a total of...” NCT00179140 ↗ |
| Route | Oral | “oral administration of protein supplement (Nepro) during hemodialysis” NCT00179140 ↗ |